Table 3.
Groups | No. of patients (n) | CT severity score (mean ± SD) |
p value |
---|---|---|---|
Age-based sub-group analysis | |||
Age < 30 | |||
Non-vaccinated | 131 | 4.6 ± 8.2 | 0.1811 |
Vaccinated | 28 | 1.9 ± 3.7 | |
Age 30–45 | |||
Non-vaccinated | 204 | 8.5 ± 10.8 | 0.0031 |
Vaccinated | 57 | 3.9 ± 6.8 | |
Age 46–60 | |||
Non-vaccinated | 151 | 14.1 ± 12.1 | 0.0341 |
Vaccinated | 76 | 9.9 ± 9.9 | |
Age > 60 | |||
Non-vaccinated | 95 | 14.8 ± 11.6 | 0.3851 |
Vaccinated | 84 | 13.1 ± 11.1 | |
Gender-based sub-group analysis | |||
Male | |||
Non-vaccinated | 373 | 10.7 ± 11.9 | 0.1541 |
Vaccinated | 161 | 8.5 ± 9.8 | |
Female | |||
Non-vaccinated | 208 | 9.2 ± 10.5 | 0.7081 |
Vaccinated | 84 | 9.5 ± 10.8 | |
Vaccinated group | |||
Male | 161 | 8.5 ± 9.8 | 0.4501 |
Female | 84 | 9.5 ± 10.8 | |
Non-vaccinated group | |||
Male | 373 | 10.7 ± 11.9 | 0.3591 |
Female | 208 | 9.2 ± 10.5 |
1Mann-Whitney U test
p values < 0.05 are considered significant (bold)